Homo sapiens (human)

Summary
Taxonomy ID
9606
PubChem Taxonomy
9606
Displaying entries 4476 - 4500 of 18496 in total
UniProt ID ▲ Protein Name Gene Symbol No. of Glycosylation Sites No. of GlyTouCan IDs Disease Ontology
F8SKX5 MHC class I antigen (Fragment)
  • HLA-B
1 0
F8SKX7 MHC class I antigen (Fragment)
  • HLA-B
1 0
F8SKY1 MHC class I antigen (Fragment)
  • HLA-C
1 0
F8SKY3 MHC class I antigen (Fragment)
  • HLA-C
1 0
F8SKY8 MHC class I antigen (Fragment)
  • HLA-C
1 0
F8SKY9 MHC class I antigen (Fragment)
  • HLA-C
1 0
F8SKZ2 MHC class I antigen (Fragment)
  • HLA-C
1 0
F8SKZ4 MHC class I antigen (Fragment)
  • HLA-C
1 0
F8SKZ5 MHC class I antigen (Fragment)
  • HLA-C
1 0
F8SKZ6 MHC class I antigen (Fragment)
  • HLA-C
1 0
F8SKZ7 MHC class I antigen (Fragment)
  • HLA-C
1 0
F8SL01 MHC class I antigen (Fragment)
  • HLA-C
1 0
F8SL02 MHC class I antigen (Fragment)
  • HLA-C
1 0
F8SY67 MHC class I antigen (Fragment)
  • HLA-Cw
1 0
F8SY72 MHC class I antigen (Fragment)
  • HLA-Cw
1 0
F8SY74 MHC class I antigen (Fragment)
  • HLA-Cw
1 0
F8TIA0 MHC class I antigen (Fragment)
  • HLA-C
1 0
F8TLS5 Proto-oncogene tyrosine-protein kinase receptor Ret
  • RET
1 0
F8TLW0 Proto-oncogene tyrosine-protein kinase receptor Ret
  • RET
1 0
F8VNV6 Decorin (Fragment)
  • DCN
1 0
F8VP57 receptor protein-tyrosine kinase
  • EPHA5
1 0
F8VR29 Carboxypeptidase M
  • CPM
1 0
F8VR77 Proliferation-associated 2G4
  • PA2G4
0 1
F8VRH0 Poly(rC) binding protein 2 (Fragment)
  • PCBP2
0 1
F8VU13 Carboxypeptidase M (Fragment)
  • CPM
1 0

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024